Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]
SAMRAT SARKAR, AMITY UNIVERSITY KOLKATA Where the entire world is trying to find a way out of this pandemic situation, Bharat Biotech with collaborated with Washington University School of Medicine in St. Louis have gone for another massive bang on the pandemic by trying a new novel chimp-adenovirus, a single-dose intranasal vaccine for Covid-19 using […]
–Thota Kanishka Rao, Amity University Kolkata Hyderabad-based Bharat Biotech in a joint effort with analysts from the ICMR’s National Institute of Virology, based in Pune has delivered the information from the creature preliminaries of its immunization competitor. It demonstrated that Covaxin had the option to produce ‘robust immune responses. The two-portion vaccination routine of Covaxin […]
–Anuska Sen, Team bioXone While the entire nation unanimously waits for India’s Covid-19 vaccine, there are various drawbacks and negativities regarding the vaccine that keeps on upsetting the world, particularly Indians. However, another disheartening news has been reported today. AstraZeneca’s Covid-19 vaccine has been paused by its partner, the Serum Institute of India. Earlier this […]
–Shrestha Dutta, Amity University Kolkata The premier batch of the ‘Gam-COVID-Vac’ [Sputnik V] immunization for the prevention of novel Coronavirus, created by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has finished the vital quality assessments in the labs of Roszdravnadzor. Russian Health Minister Mikhail Murashko had […]
